Comment on "A multicenter, randomized, double-blind, imipenem/cilastatin-controlled clinical study of cefiderocol for the treatment of complicated urinary tract infections caused by gram-negative pathogens in Chinese adults"

International Journal of Antimicrobial Agents 2026

View at publisher

Authors: Liying Chai, Hong Luo, Qiuqiong Li

DOI: 10.1016/j.ijantimicag.2026.107887

Cited by: 1

References: 3

Fields of Study & Subjects

Urinary Tract Infections Management Antibiotics Pharmacokinetics and Efficacy Antimicrobial Resistance in Staphylococcus

References 3